Press release
Japan Plasma-Derived Therapeutics Market is expected to reach US$3.53 Billion by 2033., IVIG, Albumin & Factor VIII Trends and & Investment Opportunities
Japan Plasma-Derived Therapeutics Market Size 2026
Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/japan-plasma-derived-therapeutics-market?kb
Latest M & A
Chugai Pharmaceutical completed the acquisition of Renalys Pharma (gaining exclusive rights to the IgA nephropathy drug sparsentan in Japan, Korea, and Taiwan) - a strategic acquisition in the Japan biopharma ecosystem impacting plasma-related therapeutic portfolios.
Key Players:
Takeda Pharmaceutical Company Limited, Japan Blood Products Organization, CSL Behring, Grifols, Octapharma A G, Kedrion Biopharma Inc, Baxter International, KM Biologics, Biotest AG, LFB Group
Key Development:
✅ February 2026: In Japan, leading biopharma companies expanded domestic plasma fractionation capacity to address rising demand for immunoglobulins and albumin amid an aging population.
✅ January 2026: Regulatory authorities streamlined review pathways for plasma-derived therapies targeting rare and autoimmune disorders, accelerating patient access to advanced treatments.
✅ December 2025: Strategic collaborations were announced between Japanese research institutes and global plasma therapy manufacturers to strengthen local supply chains and reduce import dependency.
✅ November 2025: Hospitals increased procurement of intravenous immunoglobulin (IVIG) products to manage neurological and hematological conditions, supporting steady market growth.
✅ October 2025: Investments in cold-chain logistics and advanced viral inactivation technologies enhanced safety standards and improved distribution efficiency nationwide.
✅ August 2025: Public-private partnerships promoted voluntary plasma donation campaigns to stabilize raw material availability and ensure long-term therapeutic production sustainability.
✅ June 2025: Expansion of reimbursement coverage for plasma-derived therapies under Japan's national health insurance system encouraged broader treatment adoption across specialty clinics.
In December 2024, Takeda Pharmaceutical Company Limited secured approval from Japan's Ministry of Health, Labour and Welfare for HYQVIA® 10% to treat agammaglobulinemia and hypogammaglobulinemia. It is Japan's first approved fSCIg therapy, enabling larger infusion volumes with less frequent dosing.
Growth Forecast Projected:
The Japan Plasma-Derived Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the Japan Plasma-Derived Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=japan-plasma-derived-therapeutics-market?kb
Key Segments:
Intravenous (IV) segment dominated the Japan Plasma-Derived Therapeutics Market, accounting for a 74% revenue share in 2025.
By Product Type: Coagulation Factors, Albumin, Protease Inhibitors, Others
By Application: Multiple Sclerosis, Neuropathies, Primary Immunodeficiency Disorders, Hemophilia, Autoimmune Diseases, Critical Care & Trauma, Others
By End User: Hospitals, Specialty Clinics, Homecare Settings, Ambulatory Surgical Centers, Others
By Source of Plasma: Whole Blood Plasma, Apheresis Plasma, Recovered Plasma
By Route of Administration: Intravenous, Subcutaneous, Intramuscular
Benefits of the Report:
Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.
Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.
Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.
Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.
Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.
Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.
Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.
Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.
Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/japan-plasma-derived-therapeutics-market?kb
FAQ
Q1: What is the current size of the Japan Plasma-Derived Therapeutics Market?
A: The Japan Plasma-Derived Therapeutics Market was valued at US$1.95 Billion in 2024 and Growth in US$2.08 Billion in 2025is forecasted to reach US$3.53 Billion by 2033
Q2: How rapidly will the Market expand?
A: The Japan Plasma-Derived Therapeutics market is projected to grow at a CAGR of 6.8% between 2026 and 2033.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Request For Custom Research: https://www.datamintelligence.com/custom-research?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Japan Plasma-Derived Therapeutics Market is expected to reach US$3.53 Billion by 2033., IVIG, Albumin & Factor VIII Trends and & Investment Opportunities here
News-ID: 4404763 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Stress Relief Supplements Market Value at US$ 1,070.27 million by 2033., Asia-Pa …
DataM Intelligence has published a new research report on "Stress Relief Supplements Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report…
Flu Vaccine Market to Reach US$ 10.74 Billion by 2033 at 7.3% CAGR; North Americ …
The Flu Vaccine Market reached US$ 5.70 billion in 2024 and is projected to reach US$ 10.74 billion by 2033, growing at a CAGR of 7.3% during the forecast period 2025 to 2033.
Flu vaccines are designed to protect individuals against influenza viruses by stimulating the immune system to produce antibodies that recognize and neutralize the virus. The vaccine is typically administered as a single dose injection into the muscle or…
Edible Straws Market (2026): Eco Packaging Industry, Plastic-Free Alternatives 2 …
DataM Intelligence has published a new research report on "Edible Straws Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report (Get…
Preventive Vaccine Market to Reach US$ 118.36 Billion by 2033 at 8.4% CAGR; Nort …
The Preventive Vaccine Market reached US$ 53.15 billion in 2023, increased to US$ 57.31 billion in 2024, and is projected to reach US$ 118.36 billion by 2033, growing at a CAGR of 8.4% during the forecast period 2025 to 2033.
Preventive vaccines are designed to protect individuals from infectious diseases before exposure, reducing disease incidence, severity, and transmission. Continuous innovations in vaccine research and development, including mRNA platforms, protein subunit vaccines,…
More Releases for Japan
Vision Guided Robotic Systems Market Size 2022 - FANUC(Japan), KUKA(Germany), AB …
The Vision Guided Robotic Systems Market research report also provides an in-depth analysis of key players in the market, including their company profiles, business offerings, recent development, market strategies, and critical observation related to the product. The research study provides extensive coverage of the Vision Guided Robotic Systems Market size across all industries and businesses. In addition, it offers detailed insights into market size and growth depending upon various segments…
Japan Agriculture Market, Japan Agriculture Industry, Japan Agriculture Livestoc …
The agriculture sector is a very significant sector in Japan. Agriculture sector exists in every part of country, but is especially essential on the northern island of Hokkaido that accounts for approximately 10% of national production. Modern methods such as commercial fertilizers, hybrid seeds, insecticides, and machinery, have been used so efficiently in farming. Japan is the second major agricultural product importer in the world (after the U.S.). Almost all…
Car Navigation ECU Market 2019: Top Key Players are AW Software (Japan), Contine …
Car Navigation ECU Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13844912
Global Car Navigation ECU market 2019 research provides a basic overview of the industry…
Global Car Navigation ECU Market Outlook to 2023 – AW Software (Japan), Contin …
An automotive navigation system is part of the automobile controls or a third party add-on used to find direction in an automobile and the ECU is the core part control it.
Car Navigation typically uses a satellite navigation device to get its position data which is then correlated to a position on a road. According to this study, over the next five years the Car Navigation ECU market will register a…
Global Car Navigation Parts Market Research Report 2019-2025 | Global Key Play …
This research report titled “Global Car Navigation Parts Market” Insights, Forecast to 2025 has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Car Navigation Parts Market during the period between 2018 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in…
Global Automotive 3D Scanning Laser Radar (3D-LiDAR) Market 2019-2025 | Velodyne …
Researchmoz added Most up-to-date research on "Global Automotive 3D Scanning Laser Radar (3D-LiDAR) Market Insights,Forecast to 2025" to its huge collection of research reports.
3D LiDAR uses a pulsed laser to detect distance, velocity and angle with high precision. LiDAR can classify objects, detect lane markings, and may also be used to accurately position an autonomous vehicle relative to a high definition map.
3D LiDAR is prominent, as it is a key…
